|
Monday, June 25, 2007: 2:45 PM-3:45 PM |
B3: Lipid Management in Women: Beyond LDL |
Suzanne Hughes |
Define the gender differences in the impact of elevated triglycerides and low HDL on CVD risk.
Summarize the clinical trial evidence that LDL-C reduction is associated with clinical benefit in women.
Outline the lifestyle and pharmacologic strategies to employ in women with elevated non-HDL-C who are on maximal therapy for LDL-C reduction. |
|
See more of The Association of Women's Health, Obstetric and Neonatal Nurses (June 23-27, 2007)